X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (3073) 3073
life sciences & biomedicine (2906) 2906
humans (2852) 2852
female (1883) 1883
male (1457) 1457
middle aged (1225) 1225
nitriles - adverse effects (1213) 1213
nitriles - therapeutic use (1176) 1176
nitriles (1101) 1101
aged (968) 968
animals (952) 952
adult (851) 851
breast neoplasms - drug therapy (721) 721
nitriles - administration & dosage (716) 716
triazoles - therapeutic use (705) 705
oncology (642) 642
treatment outcome (632) 632
triazoles - adverse effects (554) 554
nitriles - pharmacology (548) 548
pharmacology & pharmacy (481) 481
breast cancer (470) 470
analysis (427) 427
triazoles - administration & dosage (391) 391
aged, 80 and over (385) 385
antineoplastic agents, hormonal - therapeutic use (359) 359
care and treatment (341) 341
rats (330) 330
medicine & public health (322) 322
aromatase inhibitors - therapeutic use (320) 320
double-blind method (319) 319
postmenopause (315) 315
letrozole (311) 311
adamantane - analogs & derivatives (309) 309
toxicology (279) 279
antineoplastic agents, hormonal - adverse effects (275) 275
cancer (274) 274
aromatase inhibitors - adverse effects (267) 267
research (264) 264
time factors (260) 260
dose-response relationship, drug (259) 259
drug therapy, combination (254) 254
tamoxifen - therapeutic use (254) 254
drug therapy (252) 252
abridged index medicus (249) 249
breast neoplasms - pathology (246) 246
diabetes mellitus, type 2 - drug therapy (244) 244
aromatase inhibitors (243) 243
chemotherapy, adjuvant (242) 242
chemistry (241) 241
endocrinology & metabolism (238) 238
nitriles - toxicity (238) 238
physical sciences (235) 235
anastrozole (234) 234
antineoplastic agents - therapeutic use (229) 229
prostatic neoplasms - drug therapy (219) 219
clinical trials (212) 212
adamantane - therapeutic use (195) 195
obstetrics & gynecology (194) 194
health aspects (193) 193
disease-free survival (189) 189
young adult (189) 189
antineoplastic combined chemotherapy protocols - therapeutic use (188) 188
drug administration schedule (188) 188
neurosciences & neurology (188) 188
mice (186) 186
pyrethrins - toxicity (186) 186
tamoxifen (186) 186
pyrrolidines - therapeutic use (185) 185
adolescent (184) 184
antineoplastic agents - adverse effects (184) 184
environmental sciences & ecology (184) 184
environmental sciences (183) 183
nitriles - pharmacokinetics (183) 183
prospective studies (178) 178
randomized controlled trials as topic (175) 175
follow-up studies (173) 173
retrospective studies (169) 169
vildagliptin (166) 166
biochemistry & molecular biology (165) 165
internal medicine (164) 164
aromatase inhibitors - administration & dosage (161) 161
anilides - adverse effects (160) 160
anilides - therapeutic use (158) 158
general & internal medicine (158) 158
triazoles - pharmacology (158) 158
type 2 diabetes (156) 156
adamantane - adverse effects (154) 154
prostate cancer (152) 152
hypoglycemic agents - therapeutic use (149) 149
mass spectrometry (149) 149
medicine, general & internal (149) 149
parkinson disease - drug therapy (149) 149
administration, oral (148) 148
pyrrolidines - adverse effects (148) 148
estrogen (147) 147
tamoxifen - adverse effects (147) 147
clinical trials as topic (146) 146
pregnancy (145) 145
risk factors (145) 145
dermatology (143) 143
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3761) 3761
German (47) 47
Japanese (40) 40
Russian (24) 24
Spanish (23) 23
French (19) 19
Chinese (10) 10
Italian (10) 10
Dutch (5) 5
Hungarian (4) 4
Czech (3) 3
Portuguese (3) 3
Danish (1) 1
Hebrew (1) 1
Norwegian (1) 1
Persian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 02/2009, Volume 360, Issue 7, pp. 679 - 691
Journal Article
PloS one, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, pp. e0198448 - e0198448
The use of pesticides exposes humans to numerous harmful molecules. Exposure in early-life may be responsible for adverse effects in later life... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Glycine - analogs & derivatives | Glycine - adverse effects | Oxidative Stress | Humans | Proton Magnetic Resonance Spectroscopy | Female | Neonicotinoids - adverse effects | France | Morpholines - adverse effects | Disease Models, Animal | Animals, Newborn | Organophosphorus Compounds - adverse effects | Rats | Nitro Compounds - adverse effects | Toluidines - adverse effects | Chlormequat - adverse effects | Metabolomics - methods | Environmental Exposure - adverse effects | Pregnancy | Animals | Metabolome - drug effects | Carbofuran - adverse effects | Lipid Metabolism - drug effects | Pesticides - adverse effects | Infectious Disease Transmission, Vertical - statistics & numerical data | Nitriles - adverse effects | Metabolomics | Usage | Pesticides | Rattus | Influence | Research | Tricarboxylic acid cycle | Brain | Oxidative stress | Energy metabolism | Carbofuran | Cereals | Nuclear magnetic resonance--NMR | Liver | Amino acids | Insecticides | Glucose | Glyphosate | Glucose metabolism | Herbicides | Toxicology | Mitochondria | Metabolites | Rodents | Lipid metabolism | Urine | Carbohydrates | Liver diseases | Carbohydrate metabolism | Exposure | Pharmacology | Metabolism | Contamination | Molecular chains | Studies | Progeny | Offspring | Acetochlor | Imidacloprid | Females | Energy storage | Index Medicus | Life Sciences | Santé publique et épidémiologie | Nuclear magnetic resonance | NMR
Journal Article
British journal of haematology, ISSN 0007-1048, 01/2015, Volume 168, Issue 1, pp. 69 - 81
Summary Bosutinib is an oral, dual SRC/ABL1 tyrosine kinase inhibitor for resistant/intolerant chronic myeloid leukaemia (CML). We assessed the efficacy and... 
BCR‐ABL1 | CML | tyrosine kinase inhibitor | bosutinib | chronic myeloid leukaemia | Chronic myeloid leukaemia | Tyrosine kinase inhibitor | Bosutinib | BCR-ABL1 | Life Sciences & Biomedicine | Hematology | Science & Technology | Index Medicus | Haematological Malignancy
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2016, Volume 375, Issue 20, pp. 1925 - 1936
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 238 - 246
... transcriptase inhibitor (NNRTI), efavirenz, in combination with tenofovir-disoproxil-fumarate and emtricitabine.1–4 However, efavirenz is associated with several adverse... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Adenine - adverse effects | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | Organophosphonates - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Adenine - administration & dosage | Benzoxazines - therapeutic use | Organophosphonates - administration & dosage | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Aged | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Dosage and administration | Efavirenz | Patient outcomes | Clinical trials | Antiretroviral drugs | Drug therapy | Human immunodeficiency virus--HIV | Index Medicus | Abridged Index Medicus
Journal Article
PloS one, ISSN 1932-6203, 01/2020, Volume 15, Issue 1, pp. e0217192 - e0217192
Journal Article